Home | Blog | General health | Weight loss | Can you get weight loss injections with a BMI of 25?
A healthy BMI is between 18.5 and 24.9. Current studies and guidelines show that weight-loss injections should only be used for a BMI of 30 and above, or 27+ if you have certain weight-related health conditions. Taking them with a BMI below this threshold can put your health at risk and cause adverse reactions.
Despite this, some private pharmacies have begun offering weight loss injections to people with a BMI of over 25 (often under certain conditions). In this guide, we’ll explain why we’re not following suit and sticking to the guidelines instead.

There aren’t any studies involving participants with a BMI of 25; most participants have a minimum BMI of 27. This is because guidelines and research have found that taking WLIs at a low BMI can put your health at risk. This might include increasing the risk of extreme weight loss, sarcopenia, malnutrition, and bowel problems.
Some private pharmacies may offer WLIs to individuals with a BMI of 25 (just touching the overweight range), but this is considered off-label and isn’t within the approved criteria for these injections. In the UK, the Medicines and Healthcare Products Regulatory Agency (MHRA) strictly licenses these injections based on clinical safety data. For WLIs, the current criteria state that a BMI of 30, or 27 with a weight-related health condition such as diabetes, is needed to be eligible. If a pharmacy or clinician prescribes them to someone with a low BMI, they would need to be confident that the WLI is required and is likely to benefit the person using it. The prescriber could face investigation or suspension for breaching guidelines and putting the patient’s health at risk if they haven’t got robust evidence to support their decision, or if they don’t make it clear to their patient that they’re prescribing outside of its prodiuct license.
Using a WLI when starting at a healthy weight is different from managing weight loss after achieving it. For example, if someone starts with a BMI of 30 and loses weight to reach a BMI of 25, their clinician might recommend continuing the medication to maintain the weight loss. This is because evidence shows that stopping WLI can lead to weight gain of about 0.4 kg per month. Evidence suggests that within 1.5 years, the patient might return to their baseline weight, and any cardiovascular improvements, such as improved blood pressure and blood sugar levels, may revert to their pre-weight-loss levels. To prevent this, it’s best to remain on the maintenance dose and continue with a healthy diet and strength training. Your clinician will provide more tailored advice based on your health and personal needs.
What do our clinicians say?Dr Daniel said
‘We certainly wouldn't prescribe it for people with a BMI ~25 if they had never been on weight loss medication before. WLIs are licensed for maintenance, so someone who has previously been on them could be eligible. People with a BMI of 27 or more might be eligible too.
If they have other risks, like heart disease or diabetes, there’s good evidence to support use of GLP1s. If they don’t have other risks, there’s some evidence that weight loss happens but no data confirming long-term preventative health outcomes.’
Yes, you can get a WLI if you have a BMI of 27 or more, with weight-related conditions such as diabetes or heart problems. You may also be prescribed them if you were previously on WLIs to help maintain the weight you lost.
If you want to check your eligibility, complete the online consultation to see what treatments are available for you.
Weight regain after cessation of medication for weight management: Systematic review and meta-analysis. BMJ, [online] 392.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.
Have a subject you’d like us to cover in a future article? Let us know.
We're making healthcare more about you. Sign up to our newsletter for personalised health articles that make a difference.
Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.
We couldn't find what you're looking for.
Here's everything we treat. Or, if you're looking for something we don't have yet, you can suggest something.
By clicking 'Subscribe now' you're agreeing to our Privacy Policy.
(And leave your email too, so we can let you know if we write an article based on your suggestion.)
Last updated on Sep 22, 2026.
Our experts continually monitor new findings in health and medicine, and we update our articles when new info becomes available.
Sep 22, 2026
Published by: The Treated Content Team. Medically reviewed by: Dr Daniel Atkinson, GP Clinical LeadHow we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.
GP Clinical Lead
Dr Daniel oversees all matters clinical at Treated. He supports the rest of our team to make sure everything we’re doing is safe and puts patients first. He also spends a lot of time consulting with patients first hand, so he can see how well things are working and what we can improve. Registered with the GMC (No. 4624794).
MeetHow we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.